As of January 1, 2024, Marie-Kathrin Breyer took over Sylvia Hartl’s agenda and is the new director of the Ludwig Boltzmann Institute (LBI) for lung health
Respiratory diseases cause 3.9 million deaths worldwide every year. At the LBI for Lung Health, we have set ourselves the goal of making a valuable contribution to this research area with our extensive research programs. I am very pleased to be able to further advance this goal with a great team
Prim.a Priv.-Doz.in Dr.in Marie-Kathrin Breyer, PhD
Vienna (OTS) – The specialist in internal medicine, pulmonology and intensive care medicine Prim.a Priv.-Doz.in Dr. Marie-Kathrin Breyer, PhD (43) has been the new head of the since the beginning of the year LBI for lung health the Ludwig Boltzmann Society (LBG). At the Penzing Clinic in Vienna, she replaces her predecessor, University Professor Dr. Sylvia Hartl, MBA, who headed the LBI for around five years. The proven specialist in pulmonology has been working scientifically at the institute since 2012 and will continue to actively advance her research in her new role. The flagship project is Austria’s largest health study LEAD.
“Respiratory diseases cause 3.9 million deaths worldwide every year. At the LBI for Lung Health, we have set ourselves the goal of making a valuable contribution to this research area with our extensive research programs. I am very pleased to be able to further advance this goal with a great team.”
said the new director of the Ludwig Boltzmann Institute for Lung Health.
Lung Health: Research and Leadership
Breyer studied medicine at the University of Vienna and completed her PhD studies at Maastricht University. The specialist in internal medicine, pulmonology and intensive care medicine has been working at the Ludwig Boltzmann Institute for Lung Health since 2012 and was deputy director of the institute from 2021 to 2023. In addition to her new role as head of LBI, Marie-Kathrin Breyer has been head of the department for respiratory and lung diseases at the Penzing Clinic since 2023.
She supervises medical students at the Sigmund Freud Private University and the Medical University of Vienna in the preparation of their master’s and diploma theses. She is also a member of the European Respiratory Society (ERS) and the Austrian Pneumology Society (ASP).
The Viennese native has already published in various specialist media and is a founding member and scientific director of the LEAD study (Lung, hEart, sociAl, boDy), Austria’s largest observational study on lung health to date. The aim is to research the development of lung health over the entire lifespan, to find the causes and background of lung diseases and thus to open up new treatment methods for those affected in the future.
You can find a detailed portrait of Marie-Kathrin Breyer here
About Ludwig Boltzmann Society (LBG)
The Ludwig Boltzmann Society (LBG) is a non-university research and research funding organization. The focus of the content is primarily on the area of life sciences, other areas include the humanities, social sciences and cultural sciences. Together with academic and application partners, the LBG operates the Ludwig Boltzmann Institute (LBI) and develops and tests new forms of collaboration between science and non-scientific actors such as civil society, companies and the public sector. With the Clinical Research Groups (KFG) funding program, the LBG offers Austria’s first funding program in the area of non-commercial disease- and patient-oriented (translational), consortial clinical research. Parts of the LBG are the LBG Open Innovation in Science Center, which taps into the potential of open innovation for science, and the LBG Career Center, which supports young researchers in achieving their individual career goals within or outside of science. https://lbg.ac.at
Questions & Contact:
Inquiry note LBG:
Ludwig Boltzmann Society
Mag. Werner Fulterer
+43 1 513 27 50-28
werner.fulterer@lbg.ac.at